ROPIVACAINE HYDROCHLORIDE INJECTION USP
ROPIVACAINE HYDROCHLORIDE INJECTION USP
Discontinued
DIN Number
02403285
Drug Class
Human
Market Date
N/A
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02403285
AIG Number0133273001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
N01BB09 ROPIVACAINE
Product Specifications
Dosage FormSolution
Route of AdministrationEpidural
,
Block/Infiltration
AHFS Classification72:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ROPIVACAINE HYDROCHLORIDEActive
Strength: 2 MG / ML
Monograph: ROPIVACAINE HYDROCHLORIDE